MENU
+Compare
HNSPF
Stock ticker: OTC
AS OF
Jan 14 closing price
Price
$2.11
Change
+$0.11 (+5.50%)
Capitalization
9.59B

HNSPF Hansoh Pharmaceutical Group Co Ltd. Forecast, Technical & Fundamental Analysis

HNSPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for HNSPF with price predictions
Jan 08, 2025

HNSPF's Stochastic Oscillator stays in oversold zone for 10 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.479) is normal, around the industry mean (58.527). P/E Ratio (30.211) is within average values for comparable stocks, (90.460). HNSPF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.947). Dividend Yield (0.007) settles around the average of (0.122) among similar stocks. P/S Ratio (8.396) is also within normal values, averaging (19.547).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. HNSPF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HNSPF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
HNSPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
287 Xiangke Road
Phone
N/A
Employees
10523
Web
https://www.hspharm.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RPTTX48.040.32
+0.67%
T. Rowe Price Diversified Mid Cap Gr I
LZIOX16.360.09
+0.55%
Lazard International Equity Open
FFTYX16.050.07
+0.44%
AB Sustainable US Thematic Advisor
VMVIX65.440.22
+0.34%
Vanguard Mid-Cap Value Index Investor
MRIMX23.340.07
+0.30%
Victory Integrity Mid-Cap Value R6

HNSPF and Stocks

Correlation & Price change

A.I.dvisor tells us that HNSPF and RMTI have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HNSPF and RMTI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HNSPF
1D Price
Change %
HNSPF100%
N/A
RMTI - HNSPF
24%
Poorly correlated
+0.95%
AYURF - HNSPF
11%
Poorly correlated
N/A
AKAN - HNSPF
8%
Poorly correlated
-5.39%
IXHL - HNSPF
5%
Poorly correlated
+4.32%
BFRI - HNSPF
4%
Poorly correlated
+2.80%
More

Groups containing HNSPF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HNSPF
1D Price
Change %
HNSPF100%
N/A
Pharmaceuticals: Other
industry (223 stocks)
-5%
Poorly correlated
+0.11%
Pharmaceuticals
industry (309 stocks)
-7%
Poorly correlated
+0.20%